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Cutaneous exposure to solar ultraviolet B (UVB) radiation is 
well recognized as the major cause of skin cancer in humans; 
however, the precise molecular mechanisms whereby UVB 
mediates carcinogenesis remains unclear. The involvement 
of activated ras oncogenes has been demonstrated extensively 
in both animal and human skin cancers. Activated ras onco-
genes encode mutated ras p21 that exist in the guanosine 
triphosphate - bound active state and, following localization 
to the inner side of the plasma membrane, cause cellular 
transformation. This membrane association requires three 
post-translational modifications occurring at the C-terminus 
of the ras p21. The farnesylation of p21 by a cytosolic enzyme 
known as farnesyltransferase (FTase) is the critical step that 
triggers biologic functions of the ras p21. In this study, FTase 
activity was found to be substantially higher (approximately 
T he activation of different members of the ras gene family, namely, Ha-, Ki-, and N-ras, as a consequence of point mutation at codons 12, 13, or 61 has been detected in a broad spectrum of human malignancies, prompting investigation into their role in normal cel-
lul ar physiology and the importance of aberrant ras expression and 
function in human malignancies [1- 4] . All three ras oncogenes 
encode for a group of structurally related 21-kDa proteins desig-
nated as ras p21. These proteins resemble G proteins and are 
thought to play an important role in growth signal transduction 
[5,6] . 
Ras p21 exist in two states, a guanosine triphosphate (GTP) -
bound active state and a guanosine diphosphate (GDP) - bound in-
active state [7]. Active ras p21 can be converted to its inactive form 
by an intrinsic guanosine triphosphatase (GTPase) activity that is 
known to be stimulated by interaction with a GTPase activating 
protein (GAP) [2]. The ras p21 encoded by oncogenic alleles of 
cellular ras genes are often mutated in a manner that decreases their 
intrinsic GTPase activity [5] due to a conformational change in the 
guanine nucleotide binding site of the protein [8] or by a non-
productive association with GAP [9]' Thus, mutated ras p21 are de-
fective in GDP /GTP cycling, persist constitutively in the active 
GTP-bound form, and chronically stimulate as yet unknown 
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threefold) in UVB radiation-induced tumors in SKH-l 
hairless mice compared to epidermis from controls. Western 
blot analysis showed significantly higher levels ofHa-ras p21 
in both cytosolic and membrane fractions prepared from 
tumors compared to epidermis. Pan ras antibody against mu-
tated p21 at codon 12 showed very strong reactivity for ras 
val-12 p21 in tumors but not in normal epidermis, suggesting 
a gly to val substitution at 12th position in ras p21 in UVB-
induced tumors. Our data indicate that enhanced FTase ac-
tivity and the processing of overexpressed p21 in UVB-
induced tumors are correlated, and predict the role of point 
mutation at the 12th codon of the ras oncogene during pho-
tocarcinogenesis in mice. Key words: Farnesyltransferase/p21 
processing/cutaneous carcillogenesis/oncogene. ] Invest Dermatol 
102:754-758, 1994 
growth-stimulatory pathway(s) to promote the uncontrolled 
growth of tumor cells [10] . . 
In addition to guanine nucleotide interactions, the second critical 
requirement for the cell-transforming function of mutated ras p21 is 
its association with the inner side of the plasma membrane where it 
interacts with effector molecules to transduce signals from mem-
brane to the nucleus (i.e., downstream targets) [11-14] . This event 
is facilitated by at least three post-translational modifications of ras 
p21 that occur primarily at the C-terminal end, which has a consen-
sus motif Cys-Aaa-Aaa-Xaa (Cys-cysteine, Aaa-aliphatic amino 
acid and Xaa-any amino acid) termed the CAAX box [15 - 18]. The 
major post-translational modification of ras p21 required for its 
membrane localization is tne transfer of a IS-carbon farnesyl group 
to the cysteine residue of the CAAX box by a specific cytosolic 
enzyme known as farnesyItransferase (FTase), which markedly in-
creases protein hydrophobicity, thereby enhancing its affinity for 
lipid-rich membranes [15- 21]. In some mammalian tumors over-
expression of ras p21 has been confirmed [22 - 26]' thereby raising 
the question whether increased mutated cellular ras p21-
transformed cells may be required for their uncontrolled growth 
into frank tumors. In the present study we measured FTase activity 
in ultraviolet (UV) B radiation- induced benign skin tumors (papil-
lomas) in SKH-1 hairless mice and in epidermis from unirradiated 
controls, and correlated the enzyme activity with the processing of 
cytosolic ras p21. Because in some human non-melanoma skin 
cancers a point mutation at codon 12 of the Ha-ras oncogene (gly-
cine to valine amino acid substitution in ras p21) has been detected 
[27]. and because oncogenic ras p21 containing a gly to val substitu-
tion at the 12th position has shown significant malignant trans-
formation potential in NIH 3T3 cells in culture [28]. we also 
determined whether the ras val-12 p21 is present in these 
tumors. 
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MATERIALS AND METHODS 
Induction of Tumors in the Skin ofSKH-l Hairless Mice Six-week-
old female SKH-l hairless mice were obtained from Charles River Labora-
tories, Wilmington, MA. Tumors were induced on the dorsal skin of ani-
mals by repeated UVB exposure as described earlier from this laboratory 
[29]. Between 24 and 30 weeks ofUVB exp.osure, about 40% of the animals 
exhibited 4-5 tumors per mouse averag1l1g 4-6 mm 111 dIameter and 
2 - 4 mm in thickness. These tumors, identified histologically as benign 
papillomas [29], were used for the study described here. 
Preparation of Cytosolic and Membrane Fractions After sacrifice by 
cervical dislocation, cytosolic and membrane fractions were prepared from 
the epidermis of unirradiated controls, and UVB-induced tumors. Whole 
skin was removed and epidermis separated from the dermis by a brief heat 
treatment at 52 ·C for 30 seconds. A single tumor from each tumor-bearing 
mouse was removed .and used for the preparation of cytosolic and membrane 
fractions. Both epidermis and tumor were excised into smaIl pieces, homog-
enized at 4 ·C in 25 mM Tris-HCI, pH 7.4, containing 1 mM dithiothreitol 
(OTT), 1 mM MgCl2, 1 mM ethylenediamine tetraacetic acid, 1 mM ethy-
leneglycol-bis(,8-aminoethyl ether}-N,N,N',N'-tetraacetic acid and 1 mM 
phenylmethylsulfonyl fluoride, and 100,000 X g cytosolic and membrane 
fractions prepared as descnbed recently (30)' Prote1l1 concentratIon was de-
termined by the method of Bradford [31] using bovine serum albumin as a 
reference standard. 
Farnesyltransferase Assay FTase activity was assayed according to the 
procedure of Manne et al [32] with slight modifications as described recently 
l30]. In brief, the reaction mixture (10 jtl) containing 10 jtg of cytosolic or 
membrane protein, 1 tlg of purified recombinant Ha-ras p21gly. 12 (a kind gift 
of Dr. M. Campa, Burroughs Wellcome Co., Research Triangle Park, NC), 
and 1 jtl (0.2 jtCi) ofl0 tiM [3H] farnesylpyrophosphate (FPP, 20 Ci/mmol 
from New England Nuclear, Boston, MA) in 0.1 M HEPES buffer, pH 7.4, 
containing 10 mM DTTand 25 mM MgCI2' was incubated at 37·C for 1 h. 
The reaction was terminated by the addition of 10 jtl of 2 X sodium 
dodecylsulfate-polyacrylamide gel electrophoresis (SDS-PAGE) sample 
buffer (125 mM Tris-HCI, pH 6.8, containing 20% glycerol, 10% 2-mer-
captoethanol, 0.1 % bromophenol blue, and 5% SDS), and sa";l~les were 
subjected to SDS-PAGE on 12.5% polyacrylamIde gel, after bOlltng for 2 
min as described by Laemmli [33]. The radioactivity associated with the 
Ha-ras p21gly.12 protein was determined by cutting the band at - 22-kDa 
region of the gel, solubilization and destaining in 1 ml of 30% hydrogen 
peroxide, and counting in a Packard Tricarb 460 CD liquid scintillation 
counter. 
Detection ofHa-ras p21 and ras val-12 p21 in Epidermis and UVB 
Radiation-Induced Papillomas by Western Blot Analysis For the 
detection ofHa-ras p21, cytosolic fractions were used as such, and membrane 
fractions were suspended in detergent-rich lysis buffer (10 mM dibasic so-
dium phosphate, 150 mM NaCl, 0.1% SDS, 0.1% Triton X-l00, 12 mM 
sodium deoxycholate, 1 mM sodium fluoride, 0.2% sodium azide, 2 mM 
PMSF, and 0.4 trypsin inhibitory units of aprotonin per ml buffer, pH 7.2), 
ultrasonicated for two 1 O-second bursts at 4· C, and left overnight at 4· C for 
the solubilization of membrane. The solubilized homogeneous membrane 
preparations were ultracentrifuged at 100,000 X g for 40 min at 4 ·C, and 
the clear 100,000 X g supernatant, thus obtained, was used for the determi-
nation of membrane-bound Ha-ras p2L No pellet was evident after this 
100,000 X g run showing that almost all the membrane fraction was solubi-
lized in detergent-rich lysis buffer. The Ha-ras p21 was immunoprecipitated 
from cytosolic and soluble membrane fractions by the method of Crowell 
et at [34] with some modifications as described recently [30]. In brief, 500 tLg 
protein from cytosolic or soluble membrane fraction was rnixed with 10 jtl 
of an anti-v-Ha-ras (Ab-l) antibody (clone Y13-259)-protein A-agarose 
bead complex (Oncogene Science, Uniondale, NY) at 4·C for 20 h. The 
irnmunoprecipitate was washed twice with PBS and solubilized in 25 ttl of 
1 X SDS-PAGE sample buffer, subjected to SDS-PAGE on a 12.5% gel [33], 
and the resolved protein was transferred onto a nitrocellulose membrane 
[35]. The non-specific sites on the membrane were blocked, and the mem-
brane was incubated for 1 h with v-Ha-ras (Ab-l}-rat monoclonal IgG , 
(clone Y13-259, from Oncogene Science) at a concentration of 5 jtg anti-
body / ml of tris-buffered saline, pH 8.0, with 0.05% Tween-20 (TBST) 
containing 1 % gelatin. The membrane was washed twice with TBST and 
incubated for 1 h with alkaline-phosphatase-conjugated anti-Rat IgG 
(Calbiochem, LaJolla, CA) at a dilution of 1 : 5000 with TBST containing 
1 % gelatin. The membrane was then washed extensively three times with 
TBST, and incubated with alkaline-phosphatase substrate solution until the 
color developed [30]. For the detection of ras val-12 p21 in the cytosolic and 
soluble membrane fractions, 1000 jtg protein from both fractious was used 
for immunoprecipitation and the remaining steps were identical to those 
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Figure 1. Sub-cellular distribution of FTase activity in unirradiated normal 
epidermis and UVB radiation-induced tumors in SKH-l hairless mice. The 
details of enzyme assay conditions are the same as described in Materials atld 
Methods. Enzyme activity is expressed as pmol [3H]-farnesyl transferred to 
purified recombinant I·-Ja-ras p21Sly.'2/h/mg protein. The data shown are 
mean ± SEM of four assay values from four epidermis and tumor tissues; 
each assay was conducted in duplica te. 
described for Ha-ras p21 [30]. However, at the end, Pan ras val-12 (Ab-l) 
antibody (from Oncogene Science) was used at a concentration of 1 jtg/ml to 
detect the presence of ras val-12 p21 in UVB-induced tumors and unirra-
diated control epidermis. To compare the levels of total ras p21 or ras val-12 
p21 in cytosolic and membrane fractions, corresponding blots were pro-
cessed simultaneously. 
Quantitation of the Levels ofHa-ras p21 and ras val-12 p21 in Epi-
dermis and UVB Radiation-Induced Papillomas by Densitometric 
Analysis of Band I~tensity To quantitate the levels ofHa-ras p21 and ras 
val-12 p21 , the totalll1tenSlty of each band was determined by densitometric 
analysis of Western blots using a Shimadzu CS-930 TLC scanner with a 
DR-2 data recorder programmed for the area normalization. The total ab-
sorbance of each band at 595 nm (maximum absorbance was observed at this 
wa.velength) was obtained, and the percent relative intensity, as an arbitrary 
Ul11t, was calculated based on computer print out. For statistical significance 
of the data, two-tail Student t test was employed between the values obtained 
for epidermis versus papillomas. 
RESULTS 
Subcellular Distribution and Comparison ofFTase Activity 
in Epidermis and Tumors To assess the subcellular distribution 
of FTase activity in epidermis and in UVB radiation-induced 
tumors, their respective cytosolic and membrane fractions were uti-
lized. Incorporation of radioactivity as [3H] famesyl group from 
[3H]_FPP to recombinant H a-ras p21 gly-12 was measured, and is 
presented as the specific FTase activity. As shown by the data in Fig 
1, maximum FTase activity was observed in the 100,000 X g super-
natant fractions in both unirradiated epidermis and the tumor, and 
was significantly higher in tumors compared to unirradiated control 
epidermis. Virtually no enzyme activity was detectable in the mem-
brane fractions obtained from both tissues. FTase activity was also 
assayed in 1000 X g and 9000 X g supernatant fractions prepared 
from epidermis and tumors. Although enzyme activity was also 
present in these fractions , it was considerably less than that in the 
100,000 X g supernatants (data not shown). Collectively, these re-
sults show that FTase is predominantly a cytosolic enzyme. As 
shown by the data in Table I, substantially higher FTase activity was 
observed in UVB radiation- induced tumors in SKH-l hairless mice 
compared to unirradiatcd epidermis from age- and sex-matched 
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Table I. FTase Activity in Epidermis and Tumors in SKH-l 
Hairless Mice 
Source of 
Cytosol ' 
Epidermis 
Tumor 
FTase Activity 
(pmol/h/mg protein)' 
5.85 ± 0.33 
17.47 ± 0.84' 
• Normal skin from SKH-l hairless mice was removed and made fat free, epidermis 
separated from whole skin, and 100,000 X g cytosolic fraction was prepared as detailed 
in Materials "lid Met/lods. Similarly, SKH-l hairless mice bearing UVB radiation-
induced tumors were selected, and one tumor was removed from each animal for cytosol 
preparation. 
, Details of enzyme assay conditions are described in Materials alld Methods. Each assay 
was conducted in duplicate, and specific activity data shown are mean ± SEM of eight 
and [en values in case of. respectively, epidermis and tumor samples. 
, Statistically significant compared to epidermis, p < 0.001 (Student t test). 
controls. In epidermis, enzyme activity was in the range of 4.96 to 
7.80 (5 .85 ± 0.33) pmol h- I mg protein- 1 in a total of eight sam-
ples, whereas in tumors it was in the range of 12.95 to 22.06 
(17.47 ± 0.84) pmol h- 1 mg protein-I in a total of ten tumor tis-
sues. The mean ± SEM value of specific enzyme activity in tumors 
was significantly different versus that in epidermis (p < 0.001, ' 
Student t test). 
Subcellular Distribution of Ha-ras p21 in Epidermis and 
Tumors Ha-ras p21 was detected in all the cytosolic (for unpro-
cessed or non-farnesylated ras p21) and soluble membrane (for pro-
cessed or farnesylated ras p21) fractions of those epidermis and 
tumor samples that were employed for determination of enzyme 
activity; these results are shown in Fig 2. Based on molecular weight 
markers utilized in each gel (not shown in Fig 2), a single prominent 
band was evident at approximately 22 - 23 kDa in both cytosolic 
(Fig 2A) and membrane (Fig 2B) fractions obtained from epidermis 
and tumor tissues. As evident in Fig 2A, the levels of Ha-ras p21 in 
the cytosolic fractions were higher in all, but one, tumor samples 
(Fig 2A, lanes 7 -16) compared to unirradiated normal epidermis 
(Fig 2A,Ianes 1-6) from age- and sex-matched controls. Similarly, 
the levels of Ha-ras p21 were predominantly higher in membrane 
--I 
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Figure 2. Subcellular distribution of Ha-ras p21 in UVB radiation -
induced tumors in SKH-l hairless mice and unirradiated normal epidermis. 
A and B: Western blot analysis of respectively cytosolic and soluble mem-
brane fractions showing the levels of unprocessed and processed Ha-ras p21. 
In each case, 500 J.lg protein from cytosol or membrane fraction was mixed 
with 10 J.ll of an anti - v-Ha-ras antibody - protein A-agarose bead complex, 
left at 4' C for 20 hand immunoprecipitate obtained was washed with PBS 
and subjected to 50S-PAGE. Resolved protein was transferred onto':! nitro-
cellulose membrane and Ha-ras p21 was detected by utilizing v-I-Ia-ras 
(Ab-l)-rat monoclonal IgG,. Position of p21 shown by an arrow is based on 
purified recombinant Ha-ras p21 gl y. '2 and rainbow molecular weight 
markers (Amersham Life Science, Arlington Heights, IL) used as standard. 
Lanes 1- 6, epidermis; 7 - 16, UVB radiation - induced tumors. 
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fractions obtained from all the tumors (Fig 2B, lanes 7 - 16) because 
far less Ha-ras p21 was detectable in membrane fractions from nor-
mal epidermis (Fig 2B, lanes 1-6). The densitometric analysis of 
the bands for Ha-ras p21 showed that, in case of cytosolic fractions, 
the relative intensity was in the range of 1.0-18.6 (9.21 ± 3.34, 
mean ± SEM of six values) and 16.4-104.2 (56.41 ± 10.51, 
mean ± SEM of ten values) for, respectively, epidermis and tumor 
tissues. Similarly, for membrane fractions, these values were in the 
range of 1.0-6.6 (3.73 ± 0.74, mean ± SEM of six values) and 
9.2- 88.6 (40.88 ± 7.25, mean ± SEM of ten values) in case of epi-
dermis and tumors, respectively. These data clearly show signifi-
cantly higher (p < 0.001) levels ofHa-ras p21 in both cytosolic and 
membrane fractions obtained from tumors when compared to un-
irradiated control epidermis. The relative intensity data as well as 
the visualization of bands otherwise also show that the levels of 
Ha-ras p21 were higher in most of the cytosolic fractions compared 
to membrane fractions in both tumor tissue as well as normal epi-
dermis (Fig 2A versus B). 
Detection of ras val-12 p21 in Epidermis and Tumors To 
establish a possible correlation between FTase activity, p21 process-
ing and point mutation in ras oncogene in UVB tumorigenesis, the 
cytosolic and membrane fractions obtained from normal epidermis 
and UVB radiation-induced tumors were probed for the presence 
of mutated p21. Because a point mutation at codon 12 in the ras 
oncogene (gly to val amino acid change) had been shown in squa-
mous cell carcinomas obtained from sun-exposed areas of human 
subjects [27], a pan ras val-12 (Ab-l) antibody was employed to 
detect ras val-12 p21. As shown in Fig 3, no detectable levels of ras 
val-12 p21 were evident in both cytosolic (left, A) and membrane 
(left, B) fractions obtained from un irradiated epidermis (lanes 1-6); 
a single very faint band in two of the epidermal cytosolic or mem-
brane fractions was observed that was likely a non-specific binding. 
In the case ofuVB radiation-induced tumors, however, there was 
clear evidence for the expression of ras val-12 p21 in both cytosolic 
(Fig 3, left, A) and membrane (Fig 3, left, B) fractions in nine of ten 
tumor samples (lanes 7 -16). The percent relative intensity values 
(Fig 3, right, A and B) obtained from densitometric analysis of the 
bands shown in Fig 3 (left, A and B, respectively), further substan-
tiated these observations, which were evident otherwise by visual-
ization of bands. The relative intensity of bands for cytosolic val-12 
p21 was in the range of 1-10 (4.70 ± 1.35, mean ± SEM of six 
values) and 7 -159 (43 .95 ± 15.52, mean ± SEM of ten values) for , 
respectively, epidermis and tumor samples (Fig 3, right, A). Simi-
larly, these values for membrane-bound val-12 p21 were in the 
range of 0.6-4.4 (2.13 ± 0.59, mean ± SEM of six values) and 
4.2-125.1 (54.78 ± 14.04, mean ± SEM of ten values) for epider-
mis and tumors, respectively (Fig 3, right, B). Collectively, these 
data clearly show significantly higher levels of vaJ-12 p21 in both 
cytosolic (p < 0.05) and membrane (p < 0.01) fractions obtained 
from tumors when compared to unirradiated control epidermis. 
The relative intensity data also show that the levels of val-12 p21 
were higher in membrane fractions compared to cytosolic fractions 
in tumor samples (Fig 3, A versus B) . 
DISCUSSION 
The frequent detection of activated ras oncogenes in human and 
animal neoplasms derived from different tissue types suggests that 
ras oncogenes make an important contribution to the multistep 
process of carcinogenesis [1,2] . Because UVB radiation is a potent 
DNA damaging and mutagenic agent, it is likely that it initiates 
carcinogenesis by damaging DNA and inducing mutations in ras 
oncogenes [1]. There is evidence that human skin tumors contain 
point mutations in ras oncogenes [1,27,36] . Besides, Husain et. at 
[37] showed that UVB radiation-induced papillomas and carcino-
mas in SEN CAR mouse skin manifest five- to tenfold enhancement 
of Ha-ras oncogene expression, and suggested that overexpression 
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Figure 3. Detection ofval~12 mutated ras p21 in cytosolic a?d membra~e fractions prepared from UVB radiation - induced tumors in SKH-1 hairless mice 
and unirradlated normal epidermiS. Lift: Western blot analYSIS of cytosohc and soluble membrane fractIOn showll1g the levels of unprocessed and processed 
val-12 mutated p21, respectively. In each case 1000 jlg protein was immunoprecipitated with 10 jll of an anti-v-Ha-ras antibody-protein A-agarose bead 
complex, the immunoprecipitate was subjected to SDS-PAGE, resolved protein was transferred onto a nitrocellulose membrane, and val-12 mutated ras p21 
was detected by utilizing Pan ras val-12 Ab-l. Position of p21 shown by an arrow IS based on purified recombinant Ha-ras val-12 p21 and rainbow markers used 
as standard. Right: The densitometric analysis of the corresponding blots shown in left panels using a Shill1adzu CS-930 TLC scanner with a DR-2 data 
recorder. Different scales for relative intensity (an arbitrary unit) are used in A and B for better clarity in the fi gure. LOlles 1-6, epidermis; 7 - 16, UVB 
radia tion - induced tumors. 
of a ras gene by gene amplification plays a role in the UVB 
radiation-induced skin carcinogenesis. More recently, a point mu-
tation at the 61st codon of the N-ras oncogene has been reported 
in UVB-induced tumors in C3H mice [38] . D espite the fact that 
SKH-l hairless mouse has been widely employed as a model for 
UVB radiation - induced tumorigenesis, no study has been done 
to elucidate the molecular mechanism of photocarcinogenesis, 
namely, activation of ras oncogenes by point mutation, expression 
of mutated ras p21 product, and its processing to membrane for 
cell-transforming potential, in this model. 
Because m embrane association (farnesylation) of the mutated ras 
p21 is believed to be critical for its oncogenic transformation poten-
tial [15 -21], we decided to explore this process in UVB-induced 
tumorigenes is in SKH-l hairless mice. Because by differential ultra-
speed subcellular fractionation, membrane and cytosolic fractions 
can eas ily be prepared from a desired tissue, we fractionated both 
unirradiated normal epidermis and UVB radiation - induced tumors 
to d etect a) tota l unprocessed cytosolic (non-farnesylated) and pro-
cessed (membrane-bound) Ha-ras p21, and b) ras val-12 p21 in the 
same subcellular fractions. The detection of mutated p21 (val - 12 
p21) in these tumors was important because it persists constitutively 
in the active GTP-bound form and thereby stimulates growth-
stimulatory pathways to promote the uncontrolled growth of tumor 
cells [10], though only after its localization to the inner side of the 
plasma membrane [15-21]. As observed in the present study, the 
higher levels of FTase activity, and Ha-ras p21 and ras val-12 p21 
in both cytosolic and membrane fractions obtained from UVB 
radiation - induced tumors in SKH-1 hairless mice compared to un-
irradiated epidermis from controls, suggest that in UVB-induced 
neoplas ia these three events are correlated. This correlation further 
suggests a possibi lity for an association between farnesylation of 
m utated ras p21 and its function leading to the development of 
tumors. This assumption is supported by a recent study showing a 
direct link between farnesy lation and ras p21 function, where acti-
vation of a m embrane free adenylate cyclase complex in Saccharo-
myces cerevisiae by farnesyl ated ras p21 was shown to be more effec-
tive than the nonfarnesylated species [39] . These observations 
suggest that signaling by mutated ras p21 , in its GTP-bound form, is 
dependent on the farnesyl ated COOH terminus, and that identifi-
cation of a membrane component that specifically interacts with 
farnesy lated ras p21 may be important in understanding the specific 
biochemical functions of ras p21 in human malignancies, particu-
larly in photocarcinogenesis. 
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